BerandaMNKD • NASDAQ
add
MannKind Corp
$2,61
Setelah Jam Perdagangan Normal:(0,77%)+0,020
$2,63
Tutup: 18 Mar, 19.24.24 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$2,73
Rentang hari
$2,59 - $2,73
Rentang tahun
$2,52 - $6,51
Kapitalisasi pasar
804,14Â jt USD
Volume Rata-Rata
6,45Â jt
Rasio P/E
139,80
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 111,96Â jt | 45,82% |
Biaya operasional | 89,97Â jt | 156,26% |
Penghasilan bersih | -15,95Â jt | -314,87% |
Margin laba bersih | -14,24 | -247,26% |
Penghasilan per saham | 0,01 | — |
EBITDA | -1,66Â jt | -106,85% |
Tarif pajak efektif | 23,81% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 171,35Â jt | -15,82% |
Total aset | 792,18Â jt | 101,14% |
Total liabilitas | 843,20Â jt | 78,40% |
Total ekuitas | -51,02 jt | — |
Saham yang beredar | 308,10 jt | — |
Harga terhadap nilai buku | -16,06 | — |
Tingkat pengembalian aset | -2,99% | — |
Tingkat pengembalian modal | -6,40% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -15,95Â jt | -314,87% |
Kas dari operasi | -7,96Â jt | -135,14% |
Kas dari investasi | -291,96Â jt | -705,43% |
Kas dari pembiayaan | 247,41Â jt | 384,71% |
Perubahan kas bersih | -52,51Â jt | -227,52% |
Arus kas bebas | 36,38Â jt | 27,77% |
Tentang
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Didirikan
Feb 1991
Kantor pusat
Situs
Karyawan
592
